Physician profile
Randi Baculi
NPI 1801854914
$17,127.50
in general payments reported to CMS, 2019-2025
44 companies · $2,315 in 2025
The $2,315 reported for 2025 was more than what 75% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,145 · 2020: $2,386 · 2021: $1,310 · 2022: $2,133 · 2023: $3,288 · 2024: $3,550 · 2025: $2,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,137 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,136.67 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $2,424.55 | 2020-2025 | Briviact, Fintepla, Nayzilam |
| Sunovion Pharmaceuticals INC. | $1,825.91 | 2019-2022 | |
| Sk Life Science, INC. | $1,734.00 | 2020-2025 | |
| Emd Serono, INC. | $1,311.29 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $1,110.06 | 2023-2024 | Aptiom, Brovana |
| Livanova USA, INC. | $897.85 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Teva Pharmaceuticals USA, INC. | $831.85 | 2019-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Neurocrine Biosciences, INC. | $738.95 | 2022-2025 | Ingrezza, Ongentys |
| Neurelis, INC. | $693.83 | 2020-2025 | Valtoco |
| Mdd US Operations, LLC | $617.41 | 2019-2022 | |
| Abbvie INC. | $568.51 | 2021-2025 | Ubrelvy, Qulipta |
| Aucta Pharmaceuticals, INC. | $538.10 | 2024-2025 | Motpoly Xr |
| Amgen INC. | $499.67 | 2019-2022 | |
| Pfizer INC. | $399.27 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $348.03 | 2019-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randi Baculi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.